Cytotoxic T lymphocyte recognition of HLA-G in mice

Human Immunology

Volumn 55, Issue 2, 1997, Pages 127-139

  Schmidt, Cynthia M ^a,c   Garrett, Elizabeth ^c   Orr, Harry T ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c BALL STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; HLA SYSTEM; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; TRANSGENIC MOUSE;

ADULT; ANIMALS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; INFANT, NEWBORN; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RNA, MESSENGER; SKIN; T-LYMPHOCYTES, CYTOTOXIC; THYMUS GLAND;

EID: 0030704742     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00097-9     Document Type: Article

References (37)

1. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A Class I antigen, HLA-G, expressed in human trophoblasts. Science. 248:1990;220.
2. Chumbley G, King A, Holmes N, Loke YW. In situ hybridization and northern blot demonstration of HLA-G mRNA in human trophoblast populations by locus-specific oligonucleotide. Hum Immunol. 37:1993;17.
3. Lawlor DA, Zemmour J, Ennis PD, Parham P. Evolution of class-I MHC genes and proteins from natural selection to thymic selection . Annu Rev Immunol. 8:1990;23.
4. Pook MA, Woodcock V, Tassabehji M, Campbell RD, Summers CW, Taylor M, Strachan T. Characterization of an expressible nonclasical class I HLA gene. Hum Immunol. 32:1991;102.
5. Tamaki J, Arimura Y, Koda T, Fujimoto S, Fujino T, Wakisaka A, Kakinuma M. Heterogeneity of HLA-G genes identified by polymerase chain reaction/single strand conformational polymorphism (PCR/SSCO). Microbiol Immunol. 37:1993;633.
6. Morales P, Corell A, Martinez-Laso J, Martin-Villa JM, Varela P, Paz-Artal E, Allende LM, Arnaiz-Villena A. Three new HLA-G alleles and their linkage disequilibria with HLA-A. Immunogenetics. 38:1993;323.
7. Alizadeh M, Legras C, Semana G, LeBouteiller P, Genetet B, Fauchet R. Evidence for a polymorphism of HLA-G gene. Hum Immunol. 38:1993;206.
8. Van der Ven K, Ober C. HLA-G polymorphisms in African Americans. J Immunol. 153:1994;5628.
9. Shukla H, Swaroop A, Srivastava R, Weissman SM. The mRNA of a human class I gene HLA G/HLA 6 0 exhibits a restricted pattern of expression . Nucleic Acids Res. 18:1990;2189.
10. Rinke de Wit TF, Vloemans S, Van den Elsen PJ, Haworth A, Stern PL. Differential expression of the HLA class I multigene family by human embryonal carcinoma and choriocarcinoma cell lines. J Immunol. 144:1990;1080.
11. Ellis SA, Palmer MS, McMichael A. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule. J Immunol. 144:1990;731.
12. Yelavarthi KK, Fishback JL, Hunt JS. Analysis of HLA-G mRNA in human placental and extraplacental membrane cells by in situ hybridization. J Immunol. 146:1991;2847.
13. Schmidt CM, Orr HT. Maternal/fetal interactions The role of the MHC class I molecule HLA-G . Crit Rev Immunol. 13:1993;207.
14. Geraghty DE, Koller BH, Orr HT. A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci USA. 84:1987;9145.
15. Strachan T. Molecular genetics and polymorphism of class I HLA antigens. Br Med Bull. 43:1987;1.
16. Niewiesk S, Brinckmann U, Bankamp B, Sirak S, Liebert UG, ter Meulen V. Susceptibility to measles virusinduced encephalitis in mice correlates with impaired antigen presentation to cytotoxic T lymphocytes. J Virol. 67:1993;75.
17. Sprent J, Gao E-K, Webb SR. T cell reactivity to MHC molecules Immunity versus tolerance . Science. 248:1990;1357.
18. Hunziker RD, Wegmann TG. Placental immunoregulation. Crit Rev Immunol. 6:1986;245.
19. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol. 151:1993;4562.
20. Mincheva-Nilsson L, Hammarstrom S, Hammarstrom M-L. Human decidual leukocytes from early pregnancy contain high numbers of γδ+ cells and show selective down-regulation of alloreactivity. J Immunol. 149:1992;2203.
21. Schmidt CM, Chen HL, Chiu I, Ehlenfeldt RG, Hunt JS, Orr HT. Temporal and Spatial Expression of HLA-G in transgenic mice. J Immunol. 155:1995;619.
22. Schmidt CM, Ehlenfeldt RG, Athanasiou MA, Duvick LA, Heinrichs H, David CS, Orr HT. Extraembryonic expression of the human MHC class I gene HLA-G in transgenic mice Evidence for a positive regulatory region located 1 kb 5′ to the start site of transcription . J Immunol. 151:1993;2633.
23. Koller BH, Orr HT. Cloning and complete sequence of an HLA-A2 gene Analysis of two HLA-A alleles at the nucleotide level . J Immunol. 134:1985;2727.
24. Hasenkrug K, Cory J, Stimpfling J. Monoclonal antibodies defining mouse tissue antigens encoded by the H-2 region. Immunogen. 25:1987;136.
25. Chomczynski P, Sachi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156.
26. Koller BH, Ward FE, DeMars R, Orr HT. Comparison of multiple HLA-A alleles at the DNA level by using Southern blotting and HLA-A specific probes. J Immunol. 135:1985;4229.
27. Wei X, Orr HT. Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue. Hum Immunol. 29:1990;131.
28. Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci USA. 89:1992;3947.
29. Zeff RA, Gopas J, Steinhauer E, Rajan TV, Nathenson SG. Analysis of somatic cell H-2 variants to define the structural requirements for class I antigen expression. J Immunol. 137:1986;897.
30. Alonso S, Minty A, Bourlet Y, Buckingham M. Comparison of three actin-coding sequences in the mouse Evolutionary relationships between the actin genes of warm-blooded vertebrates . J Mol Evol. 23:1986;11.
31. Wunderlich J, Shearer G. Induction and measurement of cytotoxic T lymphocyte activity. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. Current Protocols in Immunology. Vol I:1991;John Wiley & Sons, Inc, New York City, New York.
32. Ulbrecht M, Rehberger B, Strobel I, Messer G, Kind P, Degitz K, Bieber T, Weiss EH. HLA-G Expression in human keratinocytes in vitro and in human skin in vivo . Eur J Immunol. 24:1994;176.
33. Rosenberg Amy S. Skin allograft rejection. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. Current Protocols in Immunology. Vol I:1991;John Wiley & Sons, Inc, New York City, New York.
34. Burt D, Johnston D, Rinke de Wit T, van den Elsen P, Stern PL. Cellular immune recognition of HLA-Gexpressing choriocarcinoma cell line JEG-3. Int J Cancer S. 6:1991;117.
35. Epstein H, Hardy R, May JS, Johnson MH, Holmes N. Expression and function of HLA-A2 1 in transgenic mice . Eur J Immunol. 19:1989;1575.
36. Barra C, Perarnau B, Gerlinger P, Lemeur M, Gillet A, Gibier P, LeMonnier FA. Analysis of the HLA-Cw3-specific cytotoxic T lymphocyte response of HLA-B7 × human β2m double transgenic mice. J Immunol. 143:1989;3117.
37. Holterman MJ, Engelhard VH. HLA antigens expressed on murine cells are preferentially recognized by murine cytotoxic T cells in the context of the H-2 major histocompatibility complex. Proc Natl Acad Sci USA. 83:1986;9699.